Sangamo Therapeutics
SGMO
SGMO
143 hedge funds and large institutions have $289M invested in Sangamo Therapeutics in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
35% less capital invested
Capital invested by funds: $448M → $289M (-$158M)
Holders
143
Holding in Top 10
1
Calls
$4.73M
Puts
$1.22M
Top Buyers
1 | +$8.87M | |
2 | +$5.75M | |
3 | +$3.3M | |
4 |
State Street
Boston,
Massachusetts
|
+$2.4M |
5 |
SCM
Sio Capital Management
New York
|
+$2.39M |
Top Sellers
1 | -$9.17M | |
2 | -$8.72M | |
3 | -$7.32M | |
4 |
CCI
Columbus Circle Investors
|
-$2.63M |
5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$2.42M |